| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Liping Bai, Fang Yan, Ruhua Deng, Rou Gu, Xianwen Zhang, Jie Ba. Thioredoxin-1 Rescues MPP Molecular neurobiology. vol 58. issue 7. 2021-07-06. PMID:33634378. |
thioredoxin-1 rescues mpp parkinson's disease (pd), a common neurodegenerative disease, is typically associated with the loss of dopaminergic neuron in the substantia nigra pars compacta (snpc). |
2021-07-06 |
2023-08-13 |
Not clear |
| Fatih Soke, Bilge Kocer, Isil Fidan, Pembe Keskinoglu, Arzu Guclu-Gundu. Effects of task-oriented training combined with aerobic training on serum BDNF, GDNF, IGF-1, VEGF, TNF-α, and IL-1β levels in people with Parkinson's disease: A randomized controlled study. Experimental gerontology. vol 150. 2021-07-02. PMID:33965556. |
parkinson's disease (pd) is a chronic neurodegenerative disease characterized by the death of dopaminergic neurons in the substantia nigra pars compacta. |
2021-07-02 |
2023-08-13 |
Not clear |
| Maria Regoni, Stefano Cattaneo, Daniela Mercatelli, Salvatore Novello, Alice Passoni, Renzo Bagnati, Enrico Davoli, Laura Croci, Gian Giacomo Consalez, Federica Albanese, Letizia Zanetti, Maria Passafaro, Giulia Maia Serratto, Alessio Di Fonzo, Flavia Valtorta, Andrea Ciammola, Stefano Taverna, Michele Morari, Jenny Sasson. Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. Cell death & disease. vol 11. issue 11. 2021-04-28. PMID:33173027. |
mutations in the park2 gene encoding the protein parkin cause autosomal recessive juvenile parkinsonism (arjp), a neurodegenerative disease characterized by dysfunction and death of dopamine (da) neurons in the substantia nigra pars compacta (snc). |
2021-04-28 |
2023-08-13 |
mouse |
| Alexandra Petie. Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson's Disease: A Review. Frontiers in neuroscience. vol 15. 2021-04-28. PMID:33897339. |
parkinson's disease (pd) is a major neurodegenerative disease characterized by massive degeneration of the dopaminergic neurons in the substantia nigra pars compacta, α-synuclein-containing lewy bodies, and neuroinflammation. |
2021-04-28 |
2023-08-13 |
Not clear |
| Meritxell Pons-Espinal, Lucas Blasco-Agell, Antonella Consigli. Dissecting the non-neuronal cell contribution to Parkinson's disease pathogenesis using induced pluripotent stem cells. Cellular and molecular life sciences : CMLS. vol 78. issue 5. 2021-03-29. PMID:33210214. |
parkinson's disease (pd) is an incurable age-linked neurodegenerative disease with characteristic movement impairments that are caused by the progressive loss of dopamine-containing neurons (dan) within the substantia nigra pars compacta. |
2021-03-29 |
2023-08-13 |
human |
| Zhihui Wan, Junxuan Xu, Yunpeng Huang, Yanhong Zhai, Zhijun Ma, Bing Zhou, Zheng Ca. Elevating bioavailable iron levels in mitochondria suppresses the defective phenotypes caused by PINK1 loss-of-function in Drosophila melanogaster. Biochemical and biophysical research communications. vol 532. issue 2. 2021-03-18. PMID:32873392. |
parkinson's disease (pd) is the second most common progressive neurodegenerative disease, which is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2021-03-18 |
2023-08-13 |
drosophila_melanogaster |
| Richard L Jayaraj, Rami Beiram, Sheikh Azimullah, Nagoor Meeran Mf, Shreesh K Ojha, Abdu Adem, Fakhreya Yousuf Jala. Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways. International journal of molecular sciences. vol 21. issue 20. 2021-02-25. PMID:33081327. |
parkinson's disease, the second common neurodegenerative disease is clinically characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta (snpc) with upregulation of neuroinflammatory markers and oxidative stress. |
2021-02-25 |
2023-08-13 |
rat |
| Dominika Fričová, Jennifer A Korchak, Abba C Zubai. Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease. NPJ Regenerative medicine. vol 5. issue 1. 2021-02-13. PMID:33298940. |
parkinson's disease (pd) is the second most common neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of lewy bodies, which gives rise to motor and non-motor symptoms. |
2021-02-13 |
2023-08-13 |
Not clear |
| Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, Jean-Noël Vallé. Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease. Cells. vol 9. issue 2. 2021-02-12. PMID:32012898. |
parkinson's disease (pd) is one of the main neurodegenerative disease characterized by a progressive degeneration of neurons constituted by dopamine in the substantia nigra pars compacta. |
2021-02-12 |
2023-08-13 |
Not clear |
| Mohammad Najim Uddin, Mohammad Injamul Hoq, Israt Jahan, Shafayet Ahmed Siddiqui, Chayan Dhar Clinton, Mohammed Ibrahim, Mohammad Safiqul Islam, Md Jakari. The mechanistic role of thymoquinone in Parkinson's disease: focus on neuroprotection in pre-clinical studies. Current molecular pharmacology. 2021-01-06. PMID:33402092. |
parkinson's disease (pd) is a long-term neurodegenerative disease with movement difficulties, and the common feature of neurodegeneration in pd patients is caused by dopaminergic neural damage in the substantia nigra pars compacta. |
2021-01-06 |
2023-08-13 |
Not clear |
| Claudio Giuliano, Francesca Siani, Liudmila Mus, Cristina Ghezzi, Silvia Cerri, Barbara Pacchetti, Chiara Bigogno, Fabio Blandin. Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease. Nutrition (Burbank, Los Angeles County, Calif.). vol 69. 2020-12-23. PMID:31586482. |
parkinson's disease (pd) is a neurodegenerative disease characterized by loss of dopaminergic neurons in the substantia nigra pars compacta (snc). |
2020-12-23 |
2023-08-13 |
rat |
| Irving Parra, Isabel Martínez, Gabriel Ramírez-García, Yousef Tizabi, Liliana Mendiet. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease. Neurotoxicity research. vol 37. issue 1. 2020-12-21. PMID:31478124. |
parkinson's disease (pd) is an idiopathic and progressive neurodegenerative disease characterized by the loss of ~ 80% of dopaminergic neurons in substantia nigra pars compacta (snpc). |
2020-12-21 |
2023-08-13 |
rat |
| Tsu-Kung Lin, Kai-Jung Lin, Kai-Lieh Lin, Chia-Wei Liou, Shang-Der Chen, Yao-Chung Chuang, Pei-Wen Wang, Jiin-Haur Chuang, Tzu-Jou Wan. When Friendship Turns Sour: Effective Communication Between Mitochondria and Intracellular Organelles in Parkinson's Disease. Frontiers in cell and developmental biology. vol 8. 2020-12-18. PMID:33330511. |
parkinson's disease (pd) is a complex neurodegenerative disease with pathological hallmarks including progressive neuronal loss from the substantia nigra pars compacta and α-synuclein intraneuronal inclusions, known as lewy bodies. |
2020-12-18 |
2023-08-13 |
human |
| Ji Wang, Fushun Wang, Dongmei Mai, Shaogang Q. Molecular Mechanisms of Glutamate Toxicity in Parkinson's Disease. Frontiers in neuroscience. vol 14. 2020-12-17. PMID:33324150. |
parkinson's disease (pd) is a common neurodegenerative disease, the pathological features of which include the presence of lewy bodies and the neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta. |
2020-12-17 |
2023-08-13 |
Not clear |
| Yan Yang, Fancong Kong, Qingqing Ding, Ying Cai, Yanlei Hao, Beisha Tan. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response. Biochemical and biophysical research communications. vol 526. issue 4. 2020-11-25. PMID:32321640. |
parkinson's disease (pd) is neurodegenerative disease, featured by a loss of dopaminergic neurons in the substantia nigra pars compacta (snpc), characteristic motor symptoms and cognitive impairment. |
2020-11-25 |
2023-08-13 |
mouse |
| Shulei Lei, Robert Power. NMR Metabolomics Analysis of Parkinson's Disease. Current Metabolomics. vol 1. issue 3. 2020-09-30. PMID:26078917. |
parkinson's disease (pd) is a neurodegenerative disease, which is characterized by progressive death of dopaminergic neurons in the substantia nigra pars compacta. |
2020-09-30 |
2023-08-13 |
Not clear |
| Xian-Si Zeng, Wen-Shuo Geng, Jin-Jing Jia, Lei Chen, Peng-Peng Zhan. Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease. Frontiers in aging neuroscience. vol 10. 2020-09-30. PMID:29719505. |
the disease is the second most common neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. |
2020-09-30 |
2023-08-13 |
Not clear |
| Bing Wang, Cun-Jin Su, Teng-Teng Liu, Yan Zhou, Yu Feng, Ya Huang, Xu Liu, Zhi-Hong Wang, Li-Hua Chen, Wei-Feng Luo, Tong Li. The Neuroprotection of Low-Dose Morphine in Cellular and Animal Models of Parkinson's Disease Through Ameliorating Endoplasmic Reticulum (ER) Stress and Activating Autophagy. Frontiers in molecular neuroscience. vol 11. 2020-09-30. PMID:29731707. |
parkinson's disease (pd) is a common neurodegenerative disease characterized the progressive loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snc). |
2020-09-30 |
2023-08-13 |
Not clear |
| Jin-Sun Park, Yea-Hyun Leem, Jung-Eun Park, Do-Yeon Kim, Hee-Sun Ki. Neuroprotective Effect of β-Lapachone in MPTP-Induced Parkinson's Disease Mouse Model: Involvement of Astroglial p-AMPK/Nrf2/HO-1 Signaling Pathways. Biomolecules & therapeutics. vol 27. issue 2. 2020-09-30. PMID:30739428. |
parkinson's disease is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons within the substantia nigra pars compacta. |
2020-09-30 |
2023-08-13 |
mouse |
| Sabyasachi Chakraborty, Satyabrata Aich, Hee-Cheol Ki. Detection of Parkinson's Disease from 3T T1 Weighted MRI Scans Using 3D Convolutional Neural Network. Diagnostics (Basel, Switzerland). vol 10. issue 6. 2020-09-28. PMID:32545609. |
parkinson's disease is a neurodegenerative disease that affects the aging population and is caused by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta (snc). |
2020-09-28 |
2023-08-13 |
human |